Generative models have gained widespread attention in recent years due to their inverse design capabilities and their potential to accelerate the molecular design and discovery processes.

Today, Latent Labs is launching Latent-X, a frontier AI model for push button protein design, outperforming competing models under identical laboratory conditions.

Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more efficient.

The significance of the A' Generative Award extends beyond mere recognition, addressing the growing importance of algorithmic and parametric design in shaping the future of creative industries.

Scientists from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine have published in the Journal of Chemical Information and Modeling on the use of ...